US Stock MarketDetailed Quotes

Xeris Pharmaceuticals (XERS)

Watchlist
  • 6.975
  • +0.075+1.09%
Trading Jun 18 14:07 ET
1.20BMarket Cap95.55P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Xeris Pharmaceuticals (XERS) Revenue Breakdown Overview

By Business/Source

Currency:USD
2026/Q1
Stock NameRevenueRatio
Recorlev49.77M59.87%
Gvoke20.8M25.02%
Keveyis11.89M14.30%
Royalty, contract and other revenue673K0.81%

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
United States291.85M100.00%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +30.06%
Sample Name
Sample Code
 +23.55%
Sample Name
Sample Code
 -12.42%
4
United States Gasoline Fund Lp
UGA
-13.22%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-13.62%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +14.81%
Sample Name
Sample Code
 +9.18%
Sample Name
Sample Code
 +9.05%
4
Zai Lab
ZLAB
+4.71%
5
Qifu Technology
QFIN
+2.40%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On June 18, 2026, U.S. President Trump announced that a U.S.-Iran memorandum of understanding had been signed at the Palace of Versailles, w Show More
美伊和平曙光初現！全球市場「拆彈式狂歡」：誰在帶頭衝鋒，升势還能跑多遠？
After the U.S.-Iran memorandum of understanding, crude oil dropped 5%, and my first instinct was to check calls on airline stocks

- No more -